Successful weaning from the IABP requires the patient to have no signs of CS with a satisfactory blood pressure on minimal or no inotropic support (target mean arterial pressure of ≥65 mmHg and ...
Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in ...
The full results of the phase III REVERSE-IT trial continue to show that ticagrelor (Brilinta)-reversing therapy bentracimab ...
Teleflex Incorporated (NYSE: TFX) has announced that its AC3 Rangeâ„¢ Intra-Aortic Balloon Pump (IABP) has received FDA 510(k) ...
ongoing IABP support across various patient transport modes, including ambulances and both fixed- and rotary-wing aircrafts. The AC3 Rangeâ„¢ IABP combines the simple interface and proprietary ...
The AC3 Range IABP is designed to provide ongoing IABP support across various patient transport modes, including ambulances and both fixed- and rotary-wing aircrafts. The AC3 Range IABP will enter ...
early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart failure did not improve 60-day ...
The rapid increase in the number of percutaneous coronary interventions being performed has led to a corresponding rise in the complexity of lesions attempted and the extent of patient ...